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 The use of immunohistochemistry has become commonplace in the field of 
cancer diagnosis.  A major limitation to the ability to use this tool effectively is the time 
consuming tasks required for the analysis of data due to the fact that it is largely done by 
hand.  Additionally, because of this, there is an inherent level of subjectivity in the results 
obtained from this process that may depend on who it is conducting the analysis.  
Therefore, there exists a need for a method that is able to quantify results from 
immunohistochemical techniques in a way that it is both time-effective and consistent in 
how each sample is treated.    
 In this study a program was developed that was able to give a quantitative 
analysis of DAB stained prostate cancer samples that mimics the results obtained by the 
conventional manual annotation method.  This program was then used further to analyze 
much larger samples that would be too time consuming to analyze in the conventional 
way, as well as to analyze a large series of samples generated in a tissue microarray.   
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A. Background on Prostate Cancer 
 
 The prostate is a gland present only in males that sits between the urinary bladder 
and the rectum whose job is to make a fluid that nourishes sperm cells which make the 
semen more liquid (1).    Prostate cancer is the second most common form of cancer in 
American men, affecting 1 out of 7 men in their lifetime, and the second leading cause of 
cancer death in American men, killing 1 in 38 American men.  It is estimated to create 
220,800 new cases and 27,540 deaths in just a year.  The risk of prostate cancer increases 
with age with 60% of cases being in men age 65 and older and the average age of the 
patient at diagnosis being 66(2).  Almost all cases of prostate cancer are 
adenocarcinomas, a type of cancer that starts in the gland cells which, in the prostate, 
create the prostate fluid.  There are other, rarer forms of prostate cancer which include 
sarcomas, small cell carcinomas, neuroendocrine tumors, and transitional cell 
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carcinomas.  Prostate cancer might start as a pre-cancerous condition, one example of 
which is Prostatic Intraepithelial Neoplasia (PIN).  PIN involves prostate gland cells that 
appear abnormal under a microscope but do not grow into other parts of the prostate.  
PIN is extremely common as almost 50% of men have low-grade PIN by age 50.  
Individuals possessing high-grade PIN have about a 1 in 5 chance of also having prostate 
cancer present in another part of the prostate.  Another pre-cancerous condition that may 
lead to prostate cancer Proliferative Inflammatory Atrophy (PIA).  PIA involves prostate 
cells that look smaller than normal under microscope after a biopsy while also possessing 
signs of inflammation.  PIA is believed to lead to either high-grade PIN or to prostate 
cancer directly (1). 
 There are various risk factors for prostate cancer including age, race/ethnicity, 
geography, family history, genetic mutations, diet, and undergoing a vasectomy.  Prostate 
cancer is rare in men under age 40, however the risk rises rapidly after age 50.  Prostate 
cancer is most common in African-American men and Caribbean men of African 
ancestry, with these individuals being twice as likely to die from prostate cancer as white 
men.  Asian-American and Hispanic/Latino men are less likely to be diagnosed with 
prostate cancer than non-Hispanic white men.  Prostate cancer is most prevalent in North 
America, northwestern Europe, Australia, and the Caribbean Islands.  Having either a 
father or brother who has had prostate cancer more than doubles the risk of the individual 
developing prostate cancer.  Increased risk for prostate cancer has also been found to be 
tied to specific genetic mutations on the BRCA1 and BRCA2 genes as well as individuals 
with Lynch Syndrome.  Eating a diet consisting of red meat, high-fat dairy products, 
along with a lack of fruits and vegetables can slightly increase the risk of developing 
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prostate cancer.  Also, men who have had a vasectomy performed on them have a slightly 
increased risk for developing prostate cancer (3).  There are a variety of treatment options 
available to patients with prostate cancer including active surveillance, surgery, radiation 
therapy, cryotherapy, hormone therapy, chemotherapy, vaccine treatments, and bone-
directed treatments.  The factors affecting which treatment is best for the patient include 
the age and life expectancy of the patient, other health conditions, stage/grade of the 
cancer, necessity for immediate treatment, success rates for different treatments, and risk 
of possible side effects of these treatments (4).   
 
 
B.  Background on Immunohistochemistry 
 
 Immunohistochemistry has been used as a complimentary method in the diagnosis 
of various forms of cancer.  Specific tumor markers, primarily proteins, have been 
identified whose levels can be used as signals for the presence of tumor cells (6).  CD31 
(aka platelet-endothelial cell adhesion molecule type 1) is an immunohistochemical stain 
that indicates endothelial cells, granulocytes, monocytes, and platelets.  CD31 is 
primarily used to identify tumors that are of endothelial origin.  MiB-1 is a nuclear non-
histone protein that is present in all stages of the cell cycle except G0.  Constantly 
proliferating cells express this protein and, therefore, it is useful in estimating the growth 
fraction of both benign and malignant tissue (5). 
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 The analysis of immunohistochemically stained tissue samples has traditionally 
been done manually by a pathologist through a process that is both time consuming and 
subjective.  The use of tissue micro arrays (TMA’s) for many studies can result in the 
development of hundreds of samples needing to be analyzed at a time.  This has led to a 
need for an automated process that can reduce the time necessary for sample analysis and 
perform consistently for every sample.   
 
 
C.  Current Use of Automated Programs for Analysis of IHC Stained Samples 
 
Automated programs have been developed to meet the need for quick analysis 
tools in analyzing IHC stained tissue in specific applications.  One example of the use of 
automated programs is to separate areas of ovarian carcinoma from the remainder of the 
sample (8).  This program was able to successfully segregate the portions of various 
TMA cores that contained carcinomas from the remainder of the sample and the 
background using the existing Genie Histology Pattern Recognition System (Leica 
Biosystems).  This system, however was not able to be used in a fully automated way as 
it still required a pathologist and technician to identify tumor regions in samples in order 
to create the input parameters for the software and also requires multiple repetitions of 
the training algorithm before it was able to produce results mimicking the original work 
done by the pathologist and technician, with each iteration of the training program 
requiring the user to provide feedback and make adjustments to the program’s results.  
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Another main limitation driving the need for the long calibration periods of the current 
methods available is that each IHC stain and cancer type requires individual attention for 
method development.  While this system is robust in its ability to potentially be used for 
multiple different types of stain and tissue, the calibration methods can lead to a less than 
ideal experience for those needing to routinely run high throughput analysis on samples 
of consistent tissue and staining methods.   
Another example of using computers to analyze IHC staining is CRImage, which 
has been used in the analysis of hematoxylin and eosin (H&E) staining (9, 10).  CRImage 
is a package extension of the R programming language, which can be downloaded and 
used freely.  This program is capable of classifying cells, segmenting samples, and 
calculating tumor cellularity, on top of R’s native statistical analysis capabilities.  There 
are, however limitations involved with CRImage that can be improved upon.  Firstly, in 
order to use CRImage, you must have some level of knowledge of the R programming 
language due to the lack of a graphical user interface which can present a large obstacle 
for medical doctors who would like to make use of the program.  Additionally, CRImage 
is not a fully automated analysis system.  While it is capable of image segmentation and 
sample classification without the need for user input, it still requires the user to enter 
commands for every process they want to use on the image and each image must be 
processed individually.  CRImage is also incapable of being used on Aperio Image 
Slides, a popular format for saving high resolution pathological images, due to their use 
of the SVS file format.  Workarounds for this problem exist but require the user to 
change the format of the image outside of the CRImage package.  Lastly, the use of the 
CRImage analysis package is limited to samples possessing H&E stain so this is not a 
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practical solution on its own for those interested in processing slides from various stain 
types. 
Computer aided techniques have also been used extensively for cell counting (11, 
12, 13).  MATLAB has been a successful platform for developing multiple cell counting 
algorithms.  These programs tend to have a more limited applications that the previous 
options, providing only information on how many cells are present and not analyzing the 
characteristics of those cells.  Many of these programs are intended for use with either 
dark field microscopy or grayscale images that possess high contrast between the items of 
interest and the background, making separating cells from the background of the image 
simpler.  These programs would not inherently be usable with DAB staining methods but 
















II. INSTRUMENTATION AND EQUIPMENT 
 
 
This program was designed using Matlab version 8.3 (R2014a) on a laptop running 
Windows 8.1 (64 bit).  The laptop possessed 8 gigabytes of physical memory and an Intel 




















A. Tissue Micro Array 
 
1. Program Startup  
 
Due to the large size of the files for the high resolution images, it is possible that 
the computer may run out of memory. For this reason, the program begins by closing all 
open windows within MATLAB, clearing the command screen, and clearing all variables 
stored in memory in order to avoid limitations associated with the hardware of the 
computer it is being run on.  Additionally, warnings have been turned off to prevent 




2. Reading in Image 
 
A scaled down version of the TMA image is first loaded in to extract necessary 
information while conserving system memory.  Information regarding the size of this 
image is gathered in order to create an all-black image of the same size. 
 
3. Isolating Core Samples 
 
The first step of separating the cores on the TMA’s is to remove the background 
of the image.  Each pixel is examined to determine whether it is part of a core or the 
background.  If the pixel is determined to be part of the background then the 
corresponding pixel on the black image is changed to white.  Some samples are not 
continuous, therefore it is necessary to manipulate the image to merge those sections.  
This is accomplished by creating a structuring element, using it to erode/dilate the image, 
creating a perimeter around the outside of the object, and filling all of the holes within the 
object to leave one whole area representing the location of the core.  In order to remove 
unwanted objects and samples that have merged together from the TMA the areas of the 
objects are analyzed, turning all areas that are either exceedingly small or large back to 





FIGURE 1 – Core Isolation 
Top Left:  The original image is shown.  Top Right:  Background is separated from the 
samples.  Bottom Left:  Holes in the samples are filled to create solid objects.  Bottom 
Right:  Small objects are removed as well as samples that are overlapping each other.  
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4. Collecting/Managing Core Location Data 
 
Centroid locations of all of the remaining white objects are collected and exported 
to a matrix with each row representing a different core, the first column representing the 
horizontal position of the centroid, and the second column representing the vertical 
position of the centroid.  A third column is then created and filled with the value equal to 
the sum of the first two columns and the entire matrix is sorted by the third column to 
find the core closest to the image’s origin, i.e. the top left corner of the image. 
 
FIGURE 2 – Centroid Matrix Excerpt 
Excerpt from the centroid matrix.  The left column shows the X position of the centroid, 
central column shows the Y position of the centroid, and the right column shows the sum 
of the first two columns. 
 
A separate location matrix is created with size equal to that of the grid of cores 
present on the TMA.  The first entry in the centroid matrix is then labeled as the first 
entry, (1,1), in the location matrix.  The program then references the centroid location of 
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the original core to search for adjacent cores, focusing first on completing the first 
column by searching the centroid matrix for entries with similar horizontal position to the 
previous core and vertical positions within a specified range away from the previous core.  
If a centroid is found to be in this expected location then that core is referenced in the 
location matrix by filling its relative position with the row number of its entry in the 
centroid matrix and the process is repeated to find the next core along the column.  If no 
core is found for an expected area then the search is expanded to look for a centroid that 
would be located two places on the grid away from the previous core and the search is 
expanded in this fashion until the next core is found.  Once the first column is complete 
there is a check to make sure a proper amount of samples were found to create a baseline 
for the row information based off of that column.  If the amount of samples is found to be 
insufficient then the program will instead attempt to create a baseline from the first row 
rather than the first column.  Once the baseline row/column is established, the program 
will then fill in the columns/rows by similar means to the previous method, using the 








FIGURE 3 – Location Matrix/TMA Direct Comparison 
Excerpt from the location matrix and the portion of the TMA it represents.  The location 
matrix is filled in with the sample number in the corresponding location of the sample on 
the TMA.  Locations where a core is not found are left as a 0, as highlighted by the red 
rectangles. 
 
Once the location matrix is complete, two columns are added to the centroid 
matrix and are filled with the row and column information for where that sample was 
placed in the location matrix.  This results in the assigning of the core to both a column 
and row for future reference.  Due to the fact that the TMA images are oriented opposite 
of the conventional numbering system being used for the rows and columns of the 
samples the value of the row and column assigned to each sample is inverted so that 
samples assigned to the first row or column are now labeled as being in the last row or 




FIGURE 4 – Core Numbering Adjustment 
Left of red line:  Centroid matrix updated with rankings based on core locations.  The 
first number represents which column the core is in while the second number represents 
which row the core is in. Right of red line:  Centroid matrix once the row and column 
information has been adjusted to match the conventional numbering system. 
 
5. Reading in Large Scale Image/Translating Location Data 
 
The large scale TMA image is now read into the program so that the cores can be 
analyzed at a higher resolution.  Due to the fact that the location information gathered for 
the centroid locations does not correspond to their locations on the larger image the pixel 






FIGURE 5 – Translation of Location Data to Large Scale Image 
Left: excerpt from the original centroid matrix.  Right:  centroid matrix updated to 
accurately reflect centroid information on the higher resolution image.  The first two 
columns, representing the X and Y positions of the center of the cores, have been scaled 
up to the new resolution. 
 
Additionally, data is read in from a spreadsheet consisting of the row location, 
column location, and Gleason Scores of the cores on the TMA.  This data is used to 
assign the proper Gleason Score to each core that was found by the program. 
 
6. Processing of Large Scale Image 
 
The scaled location data from the centroid matrix is used to identify the centroid 
locations on the large scale image.  From the area surrounding the centroid location a 
composite image is generated that consists of only one sample.  Another image of the 
same size as the single core image is created to document the analysis of the core.    First, 
the core is analyzed pixel by pixel to determine whether each pixel is part of the 
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background or the sample in question.  If it is determined that the pixel is part of the 
background then the corresponding pixel in the analysis image is set to black, whereas if 
the pixel is determined to be part of the sample then the corresponding pixel is set to 
white.  The program now takes the sum total of all of the black pixels in the analysis 
image to document how much of the image is background and the sum total of all of the 
white pixels to determine how much of the image is part of the sample.  Next the core is 
analyzed pixel by pixel to determine if there is brown stain present in that pixel.  If it is 
determined that there is brown stain present in the pixel then the corresponding pixel in 
the analysis image is set to black, whereas if there is no brown stain present in the pixel 
the corresponding location is set to white.  The total amount of stain present in the sample 







FIGURE 6 – Processing of TMA Core 
Left:  Sample of a core being analyzed individually.  Right: core on the left after being 
analyzed for the presence of stain.  The white areas reflect the location of the brown stain 
in the left image. 
 
From here, the percent of the core that is stained is found by dividing the number 
of pixels found to possess the brown stain by the number of pixels that were not found to 
be part of the background and multiplying by 100.  This data is then recorded in a new 
column of the centroid matrix and the process is repeated on the next core until all have 
been analyzed.  Once all core analysis is complete, the centroid matrix, consisting of core 
centroid locations, row and column of the core, Gleason Score of the core, and the 
percentage of the core that possessed the brown stain, is exported and saved in an excel 





FIGURE 7 – TMA Data Exportation 
Excerpt from exported excel file. The first two columns represent the X and Y locations 
for the center of the core.  The third column represents distance from the image’s origin.  
Columns 4 and 5 represent which column and row the core is located in.  The sixth 
column is the percentage of the core that was found to possess the stain, while the 
seventh column indicates the Gleason Score of the core.  Several samples are used as 











B. Whole Slice 
 
1. Initial Setup 
 
The processing of whole slice images allows for the user to process a series of 
images automatically.  In order for the program to do so, the user must set up a folder 
including all images that are to be processed.  Upon program startup the user will be 
presented with a file explorer which they will use to select the folder in which they’ve put 
the images.  The program then reads the number of SVS images present in the folder to 
determine how many images will need to be analyzed. 
 
2. Image Segmentation 
 
The program begins by accessing the file name of the image currently being 
analyzed for labeling purposes.  The program then reads in that image and collects both 
the height and width of the image.  Due to limitations associated with both the size of the 
images and the hardware used to process them, each image of the whole tissue slice needs 
to be segmented to be processed one piece at a time. The program divides the original 




FIGURE 8 – Whole Slice Image Segmentation 
The program then creates a separate image of size equal to that of the sixteen sections to 
be used during the analysis.  The program also creates variables that will be used to store 
values for the amount of pixels in the image that represent the background, sample, 
stained sample, and non-stained sample and sets them all equal to zero. 
 
3. Section Processing 
 
A series of nested for-loops begins to have the program begin to process all 
sixteen pieces one at a time.  To reduce strain on the hardware running the program, each 
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sections analysis overwrites the previous.  The program first analyzes each pixel within 
the section by categorizing it to either be a part of the sample or the background.  The 
corresponding pixel location in the composite image is then changed to either be black or 
white based on the category.  The total number of black pixels in the composite image is 
calculated, as well as the total number of white pixels in the image, and then the number 
of pixels found to be in each category is added to the variable associated with the 
category outside the for-loop during image segmentation.  Next each pixel of the section 
is categorized to either be containing the brown stain or not in a method similar to the 
sample/background categorization.  The number of white pixels present in the composite 
image is then counted to be representative of the amount of stained sample in this section.  
The amount of non-stained sample in this section is calculated by subtracting the amount 
of stained sample from the amount of total sample for the section.  These values are then 
added to the variable associated with the category outside the for-loop for storage.  This 
process then continues for each of the remaining 16 sections, continually adding the 
values found for each section to the cumulative total being tracked.   
 
4. Data Management 
 
Once the totals for the entire image has been calculated, the total pixels present in 
the image is calculated by adding the amount of background, stained sample, and non-
stained sample pixels together.  This value is then used to find the percent of the total 
image that is represented by background, stained sample, and non-stained sample.  The 
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proportion of the tissue that possesses the brown stain in found by dividing the number of 
pixels found to possess the stain by the total amount of pixels making up the sample.  At 
the end of the processing of each image the program exports the file name, percentage of 
the image that is background, possesses brown stain, and normal tissue, and the 




C. Regions of Interest 
 
1. Initial Setup 
 
The processing of the regions of interest allows for the continuous processing of 
multiple images provided that they are all located within the same folder.   The program 
begins by prompting the user to select the folder containing the images of interest.  The 
program then reads the number of tiff images present in the folder to determine how 






2. Image Analysis 
 
For each image, the program begins by reading in its filename to label the sample.  
Next, the program collects size information about the image to create a blank composite 
image of duplicate height and width.  Due to the relatively small file sizes associated with 
the ROI’s, as opposed to the whole slice images and the TMA’s, the entire image can be 
processed in one piece.  The first step is to analyze the image to separate background 
from the sample.  As the program goes through the ROI pixel by pixel, it sets the 
corresponding pixel in the composite image to either be black if it is a background pixel, 
or white if it is a part of the sample.  The sum total of all of the white pixels is then taken 
to determine the area occupied by the sample.  The program then goes over the original 
image again to separate pixels containing the stain from the rest of the image.  If the 
program determines the pixel contains the stain it will turn the corresponding location in 
the composite image white, while leaving the location black if it does not possess the 
stain.  The total number of white pixels in the composite image is then calculated to find 
the area occupied by the stain and this value is used to calculate what percent of the 
sample present in the image contains the stain.  The program then exports the images 
filename and this stain percentage to an excel file before beginning this process again on 
























FIGURE 9 – Processing Flow Chart 
Program Start 
File Type 


































A. Comparing Program to Manual Results 
 
The process of designing an automated program began with designing a system 
that could replicate the current process.  The current process had been used to analyze 
various regions of interest from existing tissue slices so these were used as the 
benchmark.  The program ran analysis for these regions possessing both MiB-1 and 
CD31 stains and calculated the ratio of the two for each region.  For both the MiB-1 and 
CD31 stains the program underreported in comparison to the manual method but 
followed the same general trend between samples.  This resulted in the ratio of the MiB-1 















FIGURE12 – ROI MiB-1/CD31 Ratio Manual/Program Comparison 
 
 In order to show that the program was showing similar results as the manual 
process the data was normalized in respect to its method.  To do this, the reported average 
stain concentrations for each sample were divided by the sample reported to possess the 
highest stain concentration, creating a scale from zero to one.  The standard deviations 
measured from the method were also transformed to match this scale.  The resultant data 




FIGURE 13 – Weighted Program and Manual MiB-1 Results 
 
FIGURE 14 – Weighted Program and Manual CD31 Results 
 Visual inspection seemed to indicate that the program was reporting the same 
relative results as the manual method due to the similarity in the trends of the graph.  To 
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having an overlap of the error bars for the two points representing the same sample would 
indicate that the weighted values are not distinctly different. 
  
FIGURE 15 – Weighted MiB-1 Results with Error Bars 
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 Analysis of this technique shows that 30 of the 43 data points (~70%) include 
overlap between the ranges of (reported averages ± one standard deviation) for the two 
methods.  This provided sufficient support for the accuracy of the automated method to 
continue developing it for further analysis. 
 
 
B. ROI/Whole Slice/TMA Analysis 
 
The program was used to analyze three different data sets: regions of interest, 
whole tissue slices, and tissue micro arrays.  For each sample within each data set there 
was an image possessing MiB-1 stain and a separate image possessing CD31 stain.  Once 
every sample had been analyzed the samples were separated into two categories based on 
the Gleason Score’s for the patient, one group consisting of all samples that possessed 
Gleason Scores of either 6 or 7, the other consisting of all samples with Gleason Scores 
of 8 or 9.  A t-test was then conducted on the difference between these two categories for 
each of the data sets in terms of their presence of MiB-1 stain, presence of CD31 stain, 
and the ratio of the amount MiB-1 stain the sample possessed to the amount of CD31 
stain the sample possessed.  The results of the t-test showed that the difference in the 
presence of the MiB-1 stain was only significant in the Region of Interest samples taken, 
the difference in the presence of CD31 stain was only significant in the TMA samples, 















Regions of Interest 1.7877 (1.0339) 3.4407 (1.2902) Yes 
Whole Slices 2.2392 (1.2554) 2.8164 (1.0900) No 















Regions of Interest 2.5050 (1.6626) 2.3213 (1.0534) No 
Whole Slices 3.0808 (1.5060) 3.3273 (1.0477) No 





FIGURE 19 – MiB-1/CD31 Ratio Results 
TABLE III 
MiB-1/CD31 RATIO RESULTS 
MiB-1/CD31 






Regions of Interest 0.8918 (0.3543) 2.0209 (0.5251) Yes 
Whole Slices 0.7161 (0.1270) 0.8451 (0.1410) Yes 




The calculations of the t-tests were done using the formula: 
𝑡 =










where t is the t-score, x represents the averages of the category, S the standard deviation 
of the category, and N the number of samples in the category, with the subscript 1 
categorizing the data with Gleason Scores of 8 or 9 and the subscript 2 categorizing the 
data with Gleason Scores of 6 or 7. 
The degrees of freedom for the t-test was determined by the formula: 
𝐷𝑜𝐹 = 𝑁1 + 𝑁2 − 2 
The results of the t-test were evaluated at the confidence level of 0.05.  The 






ROI STATISTICAL SIGNIFICANCE 
 
Regions of Interest 
     
     
MiB-1/CD31 n Average Standard Deviation Variance 
6/7 AVG 13 0.892 0.354 0.125 
8/9 AVG 9 2.021 0.525 0.276 
     
  Variance of Difference  Standard Deviation 
  0.040  0.201 
     
  t DoF p 
  5.624739336 20 0.000 
    SIGNIFICANT 
     
     
MiB-1 n Average Standard Deviation Variance 
6/7 AVG 13 1.788 1.034 1.069 
8/9 AVG 9 3.441 1.290 1.665 
     
  Variance of Difference  Standard Deviation 
  0.267  0.517 
     
  t DoF p 
  3.198 20 0.002 
    SIGNIFICANT 
     
     
CD31 n Average Standard Deviation Variance 
6/7 AVG 13 2.505 1.663 2.764 
8/9 AVG 9 2.321 1.053 1.110 
     
  Variance of Difference  Standard Deviation 
  0.336  0.580 
     
  t DoF p 
  -0.317 20 0.488 




WHOLE SLICE STATISTICAL SIGNIFICANCE 
 
Whole Slice Samples 
     
     
MiB-1/CD31 n Average Standard Deviation Variance 
6/7 AVG 9 0.716 0.127 0.016 
8/9 AVG 8 0.845 0.141 0.020 
     
  Variance of Difference  Standard Deviation 
  0.004  0.065 
     
  t DoF p 
  1.972 15 0.034 
    SIGNIFICANT  
     
     
MiB-1 n Average Standard Deviation Variance 
6/7 AVG 9 2.239 1.255 1.576 
8/9 AVG 8 2.816 1.090 1.188 
     
  Variance of Difference  Standard Deviation 
  0.324  0.569 
     
  t DoF p 
  1.015 15 0.163 
    NOT SIGNIFICANT 
     
     
CD31 n Average Standard Deviation Variance 
6/7 AVG 9 3.081 1.506 2.268 
8/9 AVG 8 3.327 1.048 1.098 
     
  Variance of Difference  Standard Deviation 
  0.389  0.624 
     
  t DoF p 
  0.395 15 0.349 






TMA STATISTICAL SIGNIFICANCE 
Tissue Micro Array 
     
     
MiB-1 
/CD31 n Average Standard Deviation Variance 
6/7 AVG 975 0.679 0.500 0.250 
8/9 AVG 132 0.456 0.406 0.165 
     
  Variance of Difference  Standard Deviation 
  0.002  0.039 
     
  t DoF p 
  5.763 1105 0.000 
    SIGNIFICANT 
     
     
MiB-1 n Average Standard Deviation Variance 
6/7 AVG 1213 0.088 0.106 0.011 
8/9 AVG 158 0.074 0.097 0.009 
     
  Variance of Difference  Standard Deviation 
  6.883E-05  8.296E-03 
     
  t DoF p 
  1.666 1369 0.096 
    NOT SIGNIFICANT  
     
     
CD31 n Average Standard Deviation Variance 
6/7 AVG 1142 0.135 0.147 0.022 
8/9 AVG 156 0.169 0.161 0.026 
     
  Variance of Difference  Standard Deviation 
  0.00018463  0.013587876 
     
  t DoF p 
  2.481 1296 0.013 













V.  DISCUSSION 
 
 
Visual inspection of the whole slices of the prostate show that there tended to be a 
high degree of heterogeneity within some of the stained samples of higher Gleason scores 
(i.e. 8 & 9), meaning that the stain was found to be densely populated in certain regions 
within the slice while being almost non-existent in other regions.  It is believed that this is 
a contributing factor in the results found for the tissue micro-array samples.  While the 
region of interest samples were selected based on the opinion that they were areas 
representative of the whole tissue, the TMA samples seemed to have a large amount of 
samples that possess next to no staining, accounting for the lower average stain 
percentages and the relatively large standard deviations in comparison to the other 
selection methods.   
 Taking this into consideration, it is believed that the results seen in the whole slice 
analysis and the analysis of the regions of interest should be the point of focus moving 
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forward.  The results of these sample types show that samples coming from patients rated 
at higher Gleason scores (8’s and 9’s) tend to express higher levels of the MiB-1 stain 
relative to the CD31 stain in comparison to samples coming from patients rated at lower 





















It has been discussed that a limitation of tissue microarrays is that, due to the 
small size of the samples taken, the tissue selected for analysis may not be representative 
of the tissue as a whole.  Additionally, this is thought to be a larger problem for epithelial 
tumors due to the heterogeneous nature of the tumors (7).  Prostate cancer primarily takes 
the form of adenocarcinomas which are formed in the epithelial tissue in the prostate 
glands which creates a cause for concern for the tissue microarrays used in this study may 
not have been representative of the larger tissue used to calculate the Gleason score for 
the sample.  It is for this reason that it is believed that primary conclusions from this 
study should be drawn from the results of the whole tissue and region of interest analysis. 
 It is the intended use of this program to be used by doctors independently as a 
supplemental means for helping them better understand the nature of their patients’ 
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condition.  With more knowledge regarding the status of the patients’ condition, 
hopefully doctors will be able to make better informed decisions as to what is the best 


















One of the remaining limitations of this program is its inability to detect 
imperfections in the source image.  If there is a problem that occurred in the generation of 
the image (e.g. sample folded over, smudges on microscope lens, foreign object in field 
of view, etc…) the program currently has no way of flagging these samples and can 
report back inaccurate data.  This is a simple process in the manual method due to the 
ability of the person performing the analysis being able to visually see what’s going on 
before the analysis and can either account for the issue or preemptively remove the 
sample before it gets put in with the other data.  It is therefore recommended that future 
work on this program be involved with ensuring that there is a way for the program to 
flag samples that could possess imperfections so that the user can then decide whether 
those samples are included in their final data or not. 
It is believed that the program developed for this study could be adapted for 
alternate future applications, especially for the use in analysis of other types of tumors 
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besides prostate tumors and other types of immunohistochemical stains.  The primary 
adjustments that would need to be made to adjust the program for these situations would 
involve changing the inclusion/exclusion criteria for what constitutes stain vs normal 
tissue in the slides.  The process by which the program goes through the various images 
and analyzes them should remain the same regardless of the content of the images.  Some 
adjustment to how the analyzed data is handled may also be necessary depending on the 
desired information. 
Additionally, if the program was to be used on a more powerful computer, the 
program could be optimized further by eliminating/changing certain steps in the process 
that were necessary due to the limitations imposed by the computer the program was 
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